Insulin-like growth factor-I stimulated DNA replication in mouse endometrial stromal cells

Ayako Inoue, Sakae Takeuchi, Sumio Takahashi

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Much evidence has suggested that sex steroid hormone-induced growth of uterine cells is mediated by polypeptide growth factors synthesized in uterine tissues. The present study aimed to clarify the effect of insulin-like growth factor-I (IGF-I) on the proliferation of mouse endometrial stromal cells obtained from immature mice. IGF-I and IGF-I receptor (type I) mRNAs were detected in the endometrial stromal cells. IGF-I increased bromodeoxyuridine (BrdU) uptake in the endometrial stromal cells, indicating an increase in DNA replication. E2 increased IGF-I mRNA levels in the endometrial stromal cells. IGF-I receptor is a tyrosine kinase receptor, and treatment with genistein, a tyrosine kinase inhibitor, reduced IGF-I-induced BrdU-uptake in the endometrial stromal cells. IGF-I signaling pathways involve mitogen-activated protein (MAP) kinase and phosphatidylinositol-3 kinase (PI-3 kinase). Treatment with 10 -7 M of the MAP kinase inhibitor PD098059 and 10-5 M of the PI-3 kinase inhibitor LY294002 decreased IGF-I-induced BrdU-uptake in the endometrial stromal cells. However, LY294002 (10-5 M) also decreased the BrdU-uptake in the absence of IGF-I treatment. These results suggest that endometrial IGF-I is involved in the proliferation of endometrial stromal cells in a paracrine or autocrine manner, and that the MAP kinase pathway is involved in DNA replication of endometrial stromal cells.

Original languageEnglish
Pages (from-to)305-313
Number of pages9
JournalJournal of Reproduction and Development
Volume51
Issue number3
DOIs
Publication statusPublished - Jun 2005

Fingerprint

stromal cells
DNA replication
Stromal Cells
insulin-like growth factor I
DNA Replication
Insulin-Like Growth Factor I
mice
Bromodeoxyuridine
mitogen-activated protein kinase
Phosphatidylinositol 3-Kinase
uptake mechanisms
IGF Type 1 Receptor
2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
phosphatidylinositol 3-kinase
Mitogen-Activated Protein Kinases
tyrosine
phosphotransferases (kinases)
uterine tissue
Messenger RNA
sex hormones

Keywords

  • Endometrium
  • IGF-I
  • MAP kinase
  • Mouse
  • PI-3 kinase

ASJC Scopus subject areas

  • Animal Science and Zoology
  • Reproductive Medicine

Cite this

Insulin-like growth factor-I stimulated DNA replication in mouse endometrial stromal cells. / Inoue, Ayako; Takeuchi, Sakae; Takahashi, Sumio.

In: Journal of Reproduction and Development, Vol. 51, No. 3, 06.2005, p. 305-313.

Research output: Contribution to journalArticle

@article{915b8dd4c81143d2ae9d629032d50d58,
title = "Insulin-like growth factor-I stimulated DNA replication in mouse endometrial stromal cells",
abstract = "Much evidence has suggested that sex steroid hormone-induced growth of uterine cells is mediated by polypeptide growth factors synthesized in uterine tissues. The present study aimed to clarify the effect of insulin-like growth factor-I (IGF-I) on the proliferation of mouse endometrial stromal cells obtained from immature mice. IGF-I and IGF-I receptor (type I) mRNAs were detected in the endometrial stromal cells. IGF-I increased bromodeoxyuridine (BrdU) uptake in the endometrial stromal cells, indicating an increase in DNA replication. E2 increased IGF-I mRNA levels in the endometrial stromal cells. IGF-I receptor is a tyrosine kinase receptor, and treatment with genistein, a tyrosine kinase inhibitor, reduced IGF-I-induced BrdU-uptake in the endometrial stromal cells. IGF-I signaling pathways involve mitogen-activated protein (MAP) kinase and phosphatidylinositol-3 kinase (PI-3 kinase). Treatment with 10 -7 M of the MAP kinase inhibitor PD098059 and 10-5 M of the PI-3 kinase inhibitor LY294002 decreased IGF-I-induced BrdU-uptake in the endometrial stromal cells. However, LY294002 (10-5 M) also decreased the BrdU-uptake in the absence of IGF-I treatment. These results suggest that endometrial IGF-I is involved in the proliferation of endometrial stromal cells in a paracrine or autocrine manner, and that the MAP kinase pathway is involved in DNA replication of endometrial stromal cells.",
keywords = "Endometrium, IGF-I, MAP kinase, Mouse, PI-3 kinase",
author = "Ayako Inoue and Sakae Takeuchi and Sumio Takahashi",
year = "2005",
month = "6",
doi = "10.1262/jrd.16076",
language = "English",
volume = "51",
pages = "305--313",
journal = "Journal of Reproduction and Development",
issn = "0916-8818",
publisher = "Japanese Society of Animal Reproduction (JSAR)",
number = "3",

}

TY - JOUR

T1 - Insulin-like growth factor-I stimulated DNA replication in mouse endometrial stromal cells

AU - Inoue, Ayako

AU - Takeuchi, Sakae

AU - Takahashi, Sumio

PY - 2005/6

Y1 - 2005/6

N2 - Much evidence has suggested that sex steroid hormone-induced growth of uterine cells is mediated by polypeptide growth factors synthesized in uterine tissues. The present study aimed to clarify the effect of insulin-like growth factor-I (IGF-I) on the proliferation of mouse endometrial stromal cells obtained from immature mice. IGF-I and IGF-I receptor (type I) mRNAs were detected in the endometrial stromal cells. IGF-I increased bromodeoxyuridine (BrdU) uptake in the endometrial stromal cells, indicating an increase in DNA replication. E2 increased IGF-I mRNA levels in the endometrial stromal cells. IGF-I receptor is a tyrosine kinase receptor, and treatment with genistein, a tyrosine kinase inhibitor, reduced IGF-I-induced BrdU-uptake in the endometrial stromal cells. IGF-I signaling pathways involve mitogen-activated protein (MAP) kinase and phosphatidylinositol-3 kinase (PI-3 kinase). Treatment with 10 -7 M of the MAP kinase inhibitor PD098059 and 10-5 M of the PI-3 kinase inhibitor LY294002 decreased IGF-I-induced BrdU-uptake in the endometrial stromal cells. However, LY294002 (10-5 M) also decreased the BrdU-uptake in the absence of IGF-I treatment. These results suggest that endometrial IGF-I is involved in the proliferation of endometrial stromal cells in a paracrine or autocrine manner, and that the MAP kinase pathway is involved in DNA replication of endometrial stromal cells.

AB - Much evidence has suggested that sex steroid hormone-induced growth of uterine cells is mediated by polypeptide growth factors synthesized in uterine tissues. The present study aimed to clarify the effect of insulin-like growth factor-I (IGF-I) on the proliferation of mouse endometrial stromal cells obtained from immature mice. IGF-I and IGF-I receptor (type I) mRNAs were detected in the endometrial stromal cells. IGF-I increased bromodeoxyuridine (BrdU) uptake in the endometrial stromal cells, indicating an increase in DNA replication. E2 increased IGF-I mRNA levels in the endometrial stromal cells. IGF-I receptor is a tyrosine kinase receptor, and treatment with genistein, a tyrosine kinase inhibitor, reduced IGF-I-induced BrdU-uptake in the endometrial stromal cells. IGF-I signaling pathways involve mitogen-activated protein (MAP) kinase and phosphatidylinositol-3 kinase (PI-3 kinase). Treatment with 10 -7 M of the MAP kinase inhibitor PD098059 and 10-5 M of the PI-3 kinase inhibitor LY294002 decreased IGF-I-induced BrdU-uptake in the endometrial stromal cells. However, LY294002 (10-5 M) also decreased the BrdU-uptake in the absence of IGF-I treatment. These results suggest that endometrial IGF-I is involved in the proliferation of endometrial stromal cells in a paracrine or autocrine manner, and that the MAP kinase pathway is involved in DNA replication of endometrial stromal cells.

KW - Endometrium

KW - IGF-I

KW - MAP kinase

KW - Mouse

KW - PI-3 kinase

UR - http://www.scopus.com/inward/record.url?scp=25444437238&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=25444437238&partnerID=8YFLogxK

U2 - 10.1262/jrd.16076

DO - 10.1262/jrd.16076

M3 - Article

VL - 51

SP - 305

EP - 313

JO - Journal of Reproduction and Development

JF - Journal of Reproduction and Development

SN - 0916-8818

IS - 3

ER -